Filing Details

Accession Number:
0002001011-24-000089
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-25 20:54:39
Reporting Period:
2024-09-23
Accepted Time:
2024-09-25 20:54:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1950232 Andrew Reardon 555 Heritage Drive
Suite 200
Jupiter FL 33458
Clo & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-23 2,000 $52.27 24,534 No 4 M Direct
Common Stock Disposition 2024-09-23 2,000 $99.60 22,534 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2024-09-23 2,000 $0.00 2,000 $52.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,944 2032-08-01 No 4 M Direct
Footnotes
  1. The stock option vests and is exercisable as to 12.5% of the underlying shares on February 1, 2023, and in 42 substantially equal monthly installments thereafter.